Third, sustained high serum levels of several biomarkers of inflammation (IL-6, ferritin, CRP), coagulation and fibrinolysis (D-dimer) and tissue damage (LDH) are associated with poor COVID-19 prognosis across critically ill patients41,42. This evidence concerns the gene IL6 and COVID-19.